PFIZER SEEKS U.S. APPROVAL FOR COVID-19 ANTI-VIRAL DRUG

Nov 05, 2021

By Gavin Day

Share on

Just a day after a COVID-19 anti-viral drug by Merck was granted approval in the U.K., Pfizer has now submitted one of its own for approval in the U.S.

Pfizer Says COVID-19 Pill Cuts Hospital, Death Risk By 90%, | Time

Pfizer says its experimental pill cuts hospitalization and death for those infected by the virus by 90%.

Pfizer is asking the U.S. Food and Drug Administration and international regulators for approval as soon as possible. They say independent experts recommended halting trials based on the strength of results.

Merck has already asked U.S. officials for approval of their antiviral pill.

Zoomer Kids
You Don't Have To Be A Zoomer To Love Zoomer Radio.
Check out what the Kids have to say!
Join Our Fan Club
Coverage Area
Downtown Toronto
96.7FM
Toronto HD
96.3 HD-2
Kingston to Windsor, Parry Sound to Pittsburgh
AM740
ZoomerRadio Logo

Recently Played: